Vimarsana
Biggest News Aggregation in the World

Lundbeck Foundation News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Lundbeck Foundation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Lundbeck Foundation Today - Breaking & Trending Today

BBCNEWS BBC News At Six March 6, 2017 - Vimarsana News

BBCNEWS BBC News At Six March 6, 2017

Cities from pollution. And coming up in the sport on bbc news Afterfacing Criticism over its make up, the fa table a series of proposals to boost diversity at board level. Good evening and welcome to the bbc news at 6. There are concerns about the future of around 4,500 people who work at Vauxhall Plants in the uk after the business was bought by a french car company. Psa which already owns peugeot and citroen has agreed a deal to buy vauxhall in britain and 0pel in germany forjust under £2 billion. Vauxhall has two factories in luton and Ellesmere Port. Unions say the fight begins now to try...

Danish king awards prestigious brain research prize to top Israeli professor - Vimarsana News

Danish king awards prestigious brain research prize to top Israeli professor

King Frederik X presents Lundbeck Foundation award to Hebrew University's Prof. Haim Sompolinsky whose groundbreaking work in computational neuroscience has advanced the understanding of higher-level brain functions

Semi-automated purification of NGS libraries - Vimarsana News

Semi-automated purification of NGS libraries

In this article, Analytik Jena explains how NGS libraries can be purified and quantified automatically.

Lennox-Gastaut Syndrome Global Clinical Trials Review 2024: - Vimarsana News

Lennox-Gastaut Syndrome Global Clinical Trials Review 2024:

Dublin, April 23, 2024 (GLOBE NEWSWIRE) -- The

Glucagon-like peptide 1 receptor agonist use and risk of thyroid cancer: Scandinavian cohort study - Vimarsana News

Glucagon-like peptide 1 receptor agonist use and risk of thyroid cancer: Scandinavian cohort study

Objective To investigate whether use of glucagon-like peptide 1 (GLP1) receptor agonists is associated with increased risk of thyroid cancer. Design Scandinavian cohort study. Setting Denmark, Norway, and Sweden, 2007-21. Participants Patients who started GLP1 receptor agonist treatment were compared with patients who started dipeptidyl peptidase 4 (DPP4) inhibitor treatment, and in an additional analysis, patients who started sodium-glucose cotransporter 2 (SGLT2) inhibitor treatment. Main outcome measures Thyroid cancer identified from nationwide cancer registers. An active-comparator new us...

Source: bmj.com